Data from Next-Generation Medicine: Combining BCR-ABL and Hedgehog-Targeted Therapies
Year: 2023
Type: other
Abstract: Disease relapse remains a major cause of death in patients with BCR-ABL–positive leukemia despite advances in treatment with kinase inhibitors. Significant efforts are underway to target pathways that maintain leukemia stem cells. Targeting these pathways holds promise for definitive leukemia eradication or improvement of the effectiveness of currently available therapies. Clin Cancer Res; 19(6); 1309–11. ©2013 AACR.
Authors: Kim-Hien T. Dao, Jeffrey W. Tyner
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361944633